Page last updated: 2024-08-23
paclitaxel and u-104
paclitaxel has been researched along with u-104 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Aparicio, S; Chafe, SC; Dedhar, S; Lock, FE; Lou, Y; McDonald, PC; Ostlund, C; Serrano, I; Supuran, CT; Winum, JY | 1 |
Other Studies
1 other study(ies) available for paclitaxel and u-104
| Article | Year |
|---|---|
Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplastic Stem Cells; Paclitaxel; Phenylurea Compounds; Spheroids, Cellular; Stem Cell Niche; Sulfonamides; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2013 |